9 results on '"S. Sebag-Peyrelevade"'
Search Results
2. Reproductive endocrinology
- Author
-
A. Nazzaro, A. Salerno, L. Di Iorio, G. Landino, S. Marino, E. Pastore, F. Fabregues, A. Iraola, G. Casals, M. Creus, S. Peralta, J. Penarrubia, D. Manau, S. Civico, J. Balasch, I. Lindgren, Y. L. Giwercman, E. Celik, I. Turkcuoglu, B. Ata, A. Karaer, P. Kirici, B. Berker, J. Park, J. Kim, J. Rhee, M. Krishnan, O. Rustamov, R. Russel, C. Fitzgerald, S. Roberts, S. Hapuarachi, B. K. Tan, R. S. Mathur, A. van de Vijver, C. Blockeel, M. Camus, N. Polyzos, L. Van Landuyt, H. Tournaye, N. O. Turhan, D. Hizli, Z. Kamalak, A. Kosus, N. Kosus, H. Kafali, A. Lukaszuk, M. Kunicki, J. Liss, A. Bednarowska, G. Jakiel, K. Lukaszuk, M. Lukaszuk, B. Olszak-Sokolowska, T. Wasniewski, M. Neuberg, V. Cavalcanti, C. Peluso, B. L. Lechado, E. B. Cordts, D. M. Christofolini, C. P. Barbosa, B. Bianco, C. A. Venetis, E. M. Kolibianakis, J. Bosdou, B. C. Tarlatzis, M. Onal, D. N. Gungor, M. Acet, S. Kahraman, E. Kuijper, J. Twisk, M. Caanen, T. Korsen, P. Hompes, M. Kushnir, A. Rockwood, W. Meikle, C. B. Lambalk, X. Yan, X. Dai, J. Wang, N. Zhao, Y. Cui, J. Liu, F. Yarde, A. H. E. M. Maas, A. Franx, M. J. C. Eijkemans, J. T. Drost, B. B. van Rijn, J. van Eyck, Y. T. van der Schouw, F. J. M. Broekmans, F. Martyn, B. Anglim, M. Wingfield, T. Fang, G. J. Yan, H. X. Sun, Y. L. Hu, J. Chrudimska, P. Krenkova, M. Macek, J. Teixeira da Silva, M. Cunha, J. Silva, P. Viana, A. Goncalves, N. Barros, C. Oliveira, M. Sousa, A. Barros, S. M. Nelson, S. M. Lloyd, A. McConnachie, A. Khader, R. Fleming, D. A. Lawlor, L. Thuesen, A. N. Andersen, A. Loft, J. Smitz, M. Abdel-Rahman, S. Ismail, J. Silk, M. Abdellah, A. H. Abdellah, F. Ruiz, M. Cruz, M. Piro, D. Collado, J. A. Garcia-Velasco, A. Requena, Z. Kollmann, N. A. Bersinger, B. McKinnon, S. Schneider, M. D. Mueller, M. von Wolff, A. Vaucher, B. Weiss, P. Stute, U. Marti, J. Chai, W. Y. T. Yeung, C. Y. V. Lee, W. H. R. Li, P. C. Ho, H. Y. E. Ng, S. M. Kim, S. H. Kim, B. C. Jee, S. Ku, C. S. Suh, Y. M. Choi, J. G. Kim, S. Y. Moon, J. H. Lee, S. G. Kim, Y. Y. Kim, H. J. Kim, K. H. Lee, I. H. Park, H. G. Sun, Y. I. Hwang, N. Y. Sung, M. H. Choi, S. H. Cha, C. W. Park, J. Y. Kim, K. M. Yang, I. O. Song, M. K. Koong, I. S. Kang, H. O. Kim, C. Haines, W. Y. Wong, W. S. Kong, L. P. Cheung, T. K. Choy, P. C. Leung, R. Fadini, G. Coticchio, M. M. Renzini, M. C. Guglielmo, F. Brambillasca, A. Hourvitz, D. F. Albertini, P. Novara, M. Merola, M. Dal Canto, J. A. A. Iza, J. L. DePablo, C. Anarte, A. Domingo, E. Abanto, G. Barrenetxea, R. Kato, S. Kawachiya, D. Bodri, M. Kondo, T. Matsumoto, L. G. L. Maldonado, A. S. Setti, D. P. A. F. Braga, A. Iaconelli, E. Borges, C. Iaconelli, R. C. S. Figueira, K. Kitaya, S. Taguchi, M. Funabiki, Y. Tada, T. Hayashi, Y. Nakamura, M. Snajderova, D. Zemkova, V. Lanska, L. Teslik, R. N. - Calonge, L. Ortega, A. Garcia, S. Cortes, A. Guijarro, P. C. Peregrin, M. Bellavia, M. H. Pesant, D. Wirthner, L. Portman, D. de Ziegler, D. Wunder, X. Chen, S. H. L. Chen, Y. D. Liu, T. Tao, L. J. Xu, X. L. Tian, D. S. H. Ye, Y. X. He, A. Carby, E. Barsoum, S. El-Shawarby, G. Trew, S. Lavery, N. Mishieva, N. Barkalina, I. Korneeva, T. Ivanets, A. Abubakirov, R. Chavoshinejad, G. m. Hartshorne, W. Marei, A. a. Fouladi-nashta, G. Kyrkou, E. Trakakis, C. H. Chrelias, E. Alexiou, K. Lykeridou, G. Mastorakos, N. Bersinger, H. Ferrero, R. Gomez, C. M. Garcia-Pascual, C. Simon, A. Pellicer, A. Turienzo, B. Lledo, J. Guerrero, J. A. Ortiz, R. Morales, J. Ten, J. Llacer, R. Bernabeu, V. De Leo, R. Focarelli, A. Capaldo, A. Stendardi, L. Gambera, A. L. Marca, P. Piomboni, J. J. Kim, J. H. Kang, K. R. Hwang, S. J. Chae, S. H. Yoon, S. Y. Ku, S. Iliodromiti, T. W. Kelsey, R. A. Anderson, H. J. Lee, A. Weghofer, V. A. Kushnir, A. Shohat-Tal, E. Lazzaroni, D. H. Barad, N. N. Gleicher, T. Shavit, E. Shalom-Paz, O. Fainaru, M. Michaeli, E. Kartchovsky, A. Ellenbogen, J. Gerris, F. Vandekerckhove, A. Delvigne, N. Dhont, B. Madoc, J. Neyskens, M. Buyle, E. Vansteenkiste, E. De Schepper, L. Pil, N. Van Keirsbilck, W. Verpoest, D. Debacquer, L. Annemans, P. De Sutter, M. Von Wolff, N. a. Bersinger, F. F. Verit, S. Keskin, A. K. Sargin, S. Karahuseyinoglu, O. Yucel, S. Yalcinkaya, A. N. Comninos, C. N. Jayasena, G. M. K. Nijher, A. Abbara, A. De Silva, J. D. Veldhuis, R. Ratnasabapathy, C. Izzi-Engbeaya, A. Lim, D. A. Patel, M. A. Ghatei, S. R. Bloom, W. S. Dhillo, M. Colodron, J. J. Guillen, D. Garcia, O. Coll, R. Vassena, V. Vernaeve, H. Pazoki, G. Bolouri, F. Farokhi, M. A. Azarbayjani, M. S. Alebic, N. Stojanovic, R. Abali, A. Yuksel, C. Aktas, C. Celik, S. Guzel, G. Erfan, O. Sahin, H. Zhongying, L. Shangwei, M. Qianhong, F. Wei, L. Lei, X. Zhun, W. Yan, A. De Baerdemaeker, K. Tilleman, S. Vansteelandt, J. B. A. Oliveira, R. L. R. Baruffi, C. G. Petersen, A. L. Mauri, A. M. Nascimento, L. Vagnini, J. Ricci, M. Cavagna, F. C. Massaro, A. Pontes, J. G. Franco, W. El-khayat, M. Elsadek, F. Foroozanfard, H. Saberi, A. Moravvegi, M. Kazemi, Y. S. Gidoni, A. Raziel, S. Friedler, D. Strassburger, D. Hadari, E. Kasterstein, I. Ben-Ami, D. Komarovsky, B. Maslansky, O. Bern, R. Ron-El, M. P. Izquierdo, F. Araico, O. Somova, O. Feskov, I. Feskova, I. Bezpechnaya, I. Zhylkova, O. Tishchenko, S. K. Oguic, D. P. Baldani, L. Skrgatic, V. Simunic, H. Vrcic, D. Rogic, J. Juras, M. S. Goldstein, L. Garcia De Miguel, M. C. Campo, A. Gurria, J. Alonso, A. Serrano, E. Marban, L. Shalev, Y. Yung, G. Yerushalmi, C. Giovanni, J. Has, E. Maman, M. Monterde, A. Marzal, O. Vega, J. m. Rubio, C. Diaz-Garcia, A. Eapen, A. Datta, A. Kurinchi-selvan, H. Birch, G. M. Lockwood, M. C. Ornek, U. Ates, T. Usta, C. P. Goksedef, A. Bruszczynska, J. Glowacka, K. Jaguszewska, S. Oehninger, S. Nelson, P. Verweij, B. Stegmann, H. Ando, T. Takayanagi, H. Minamoto, N. Suzuki, N. Rubinshtein, S. Saltek, B. Demir, B. Dilbaz, C. Demirtas, W. Kutteh, B. Shapiro, H. Witjes, K. Gordon, M. P. Lauritsen, A. Pinborg, N. L. Freiesleben, A. L. Mikkelsen, M. R. Bjerge, P. Chakraborty, S. K. Goswami, B. N. Chakravarty, M. Mittal, R. Bajoria, N. Narvekar, R. Chatterjee, J. G. Bentzen, T. H. Johannsen, T. Scheike, L. Friis-Hansen, S. Sunkara, A. Coomarasamy, R. Faris, P. Braude, Y. Khalaf, A. Makedos, S. Masouridou, K. Chatzimeletiou, L. Zepiridis, A. Mitsoli, G. Lainas, I. Sfontouris, A. Tzamtzoglou, D. Kyrou, T. Lainas, A. Fermin, L. Crisol, A. Exposito, B. Prieto, R. Mendoza, R. Matorras, Y. Louwers, O. Lao, M. Kayser, A. Palumbo, V. Sanabria, J. P. Rouleau, M. Puopolo, M. J. Hernandez, J. M. Rubio, S. Ozturk, B. Sozen, A. Yaba-Ucar, D. Mutlu, N. Demir, H. Olsson, R. Sandstrom, L. Grundemar, E. Papaleo, L. Corti, E. Rabellotti, V. S. Vanni, M. Potenza, M. Molgora, P. Vigano, M. Candiani, M. Fernandez-Sanchez, E. Bosch, H. Visnova, P. Barri, B. J. C. M. Fauser, J. C. Arce, P. Peluso, C. M. Trevisan, F. A. Fonseca, P. Bakas, N. Vlahos, D. Hassiakos, D. Tzanakaki, O. Gregoriou, A. Liapis, G. Creatsas, E. Adda-Herzog, J. Steffann, S. Sebag-Peyrelevade, M. Poulain, A. Benachi, R. Fanchin, D. Zhang, F. Aybar, S. Temel, O. Hamdine, N. S. Macklon, J. S. Laven, B. J. Cohlen, A. Verhoeff, P. A. van Dop, R. E. Bernardus, G. J. E. Oosterhuis, C. A. G. Holleboom, G. C. van den Dool-Maasland, H. J. Verburg, P. F. M. van der Heijden, A. Blankhart, B. C. J. M. Fauser, F. J. Broekmans, J. Bhattacharya, A. Mitra, G. B. Dutta, A. Kundu, M. Bhattacharya, S. Kundu, P. Pigny, A. Dassonneville, S. Catteau-Jonard, C. Decanter, D. Dewailly, J. Pouly, F. Olivennes, N. Massin, M. Celle, N. Caizergues, M. Gaudoin, M. Messow, L. Vanhove, M. Peigne, P. Thomas, and G. Robin
- Subjects
Gynecology ,Gerontology ,medicine.medical_specialty ,Index (economics) ,Reproductive Medicine ,business.industry ,Rehabilitation ,Obstetrics and Gynecology ,Medicine ,Stimulation ,business - Abstract
Sao Paulo State Univ UNESP, Ctr Human Reprod Prof Franco Jr, Paulista Ctr Diag Res & Training, Dept Gynecol & Obstet,Botucatu Med Sch, Ribeirao Preto, Brazil
- Published
- 2013
- Full Text
- View/download PDF
3. Uterine Contractility and Embryo Transfer
- Author
-
S. Sebag-Peyrelevade and Renato Fanchin
- Subjects
media_common.quotation_subject ,Uterus ,Embryo ,Biology ,Uterine contractility ,Embryo transfer ,Endometrial cavity ,Contractility ,Andrology ,Human reproduction ,medicine.anatomical_structure ,medicine ,Ovulation ,media_common - Abstract
Uterine contractility of the non-pregnant uterus is likely to play an important role in human reproduction, in particular, in the embryo implantation process. After ovulation, contractility is characterized by a relative quiescence in response to the level of progesterone produced. The development of high-resolution ultrasound probes has enabled the visualization of the myometrial activity in a non-invasive way. It can also provide additional characteristics such as amplitude and direction. The nearly quiescent contractility reached at hCG+ 7 days may favour embryo permanence in the endometrial cavity, and therefore, assist implantation. Studying and understanding contractility of the non-pregnant uterus can improve embryo transfers and implantation rates.
- Published
- 2015
- Full Text
- View/download PDF
4. [The influence of exogenous LH/hCG activity on serum progesterone levels on the day of hCG administration in in vitro fertilization]
- Author
-
S, Sebag-Peyrelevade, H, El Hachem, V, Gallot, V-K, Genro, and R, Fanchin
- Subjects
Adult ,Ovarian Follicle ,Humans ,Female ,Fertilization in Vitro ,Follicle Stimulating Hormone ,Luteinizing Hormone ,Chorionic Gonadotropin ,Progesterone - Abstract
Clarifying whether the addition of recombinant LH (rLH) to recombinant FSH (rFSH) leads to progesterone (P4) levels on dhCG comparable to those obtained with stimulation with FSH and hCG (HP-hMG) MATERIALS AND METHODS: Pituitary-desensitized patients, matched for age and follicle reserve, received rFSH+LH (n=729) or HP-hMG (n=729). In the rFSH+rLH group, rLH (75 UI/day) was started at day 6. To control for the influence of ovarian response on P4, we divided serum P4 levels by the number of growing follicles (13-22 mm; "per follicle" P4 levels) and performed a multivariate analysis.Serum P4 levels on dHCG were lower in the HP-hMG (median: 0.63 ng/mL, max-min: 0.10-2.97) than in the rFSH+rLH group (0.91 ng/mL; 0.10-4.65, P0.0001), as well as "per-follicle" P4 levels (0.055 ng/mL/growing follicle, 0.006-0.284 vs 0.077 ng/mL/growing follicle, 0.003-0.336; P0.0001).HP-hMG led to lower P4 levels on day hCG than rFSH+rLH irrespective of the intensity of the ovarian response and the adjunction of rLH (75 IU/day from day 6 onward).
- Published
- 2014
5. Ovarian tissue and follicle transplantation as an option for fertility preservation
- Author
-
Michael Grynberg, Marine Poulain, Soizic le Parco, Nelly Frydman, S. Sebag-Peyrelevade, and Renato Fanchin
- Subjects
endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Ovary ,Transplantation, Autologous ,Ovarian Follicle ,Neoplasms ,medicine ,Humans ,Ovarian tissue cryopreservation ,Fertility preservation ,Ovarian follicle ,Cryopreservation ,business.industry ,Female infertility ,Obstetrics and Gynecology ,Cancer ,medicine.disease ,female genital diseases and pregnancy complications ,Premature ovarian failure ,Surgery ,Transplantation ,medicine.anatomical_structure ,Reproductive Medicine ,Female ,business ,Infertility, Female - Abstract
Objective To review and summarize data from the scientific literature on ovarian tissue and follicle transplantation as an option for fertility preservation. Design Review of pertinent literature. Setting University hospital. Patient(s) Women having undergone ovarian tissue transplantation. Intervention(s) None. Main Outcome Measure(s) Review of the literature. Result(s) Over the last decade, the field of ovarian transplantation and cryopreservation has significantly progressed, becoming applicable in humans. Indeed, fresh and frozen cortical ovarian tissue transplantations have been successfully reported worldwide, resulting in around 28 healthy babies. Although ovarian-tissue harvesting seems to be safe, the risk of reimplantation of cancer from ovarian cortical transplants cannot be estimated at this time. As a consequence, auto-transplantation of ovarian tissue in women having suffered from systemic hematological malignancies is not recommended. In these situations, reimplantation of isolated ovarian follicles might represent an interesting option in the future. Conclusion(s) Although the clinical experience is limited, the robust results obtained open new perspectives for the management of premature ovarian failure resulting or not from gonadotoxic treatments.
- Published
- 2012
6. Natural ovarian stimulation (NATOS): an innovative controlled ovarian hyperstimulation (COH) protocol that combines large oocyte availability and physiologic estrogenic environment
- Author
-
Michael Grynberg, S. Le Parco, Elodie Adda-Herzog, M. Poulain, R. Fanchin, and S. Sebag-Peyrelevade
- Subjects
Andrology ,medicine.anatomical_structure ,Reproductive Medicine ,business.industry ,medicine ,Obstetrics and Gynecology ,Stimulation ,Controlled ovarian hyperstimulation ,Oocyte ,business - Published
- 2013
- Full Text
- View/download PDF
7. Despite the addition of recombinant LH, recombinant FSH leads to higher progesterone (P4) levels of the day of hCG than FSH-hCG preparations but this phenomenon does not alter IVF-ET outcome
- Author
-
Michael Grynberg, S. Le Parco, R. Fanchin, V. Gallot, M. Poulain, and S. Sebag-Peyrelevade
- Subjects
Recombinant fsh ,medicine.medical_specialty ,Endocrinology ,Reproductive Medicine ,business.industry ,law ,Internal medicine ,Recombinant DNA ,Obstetrics and Gynecology ,Medicine ,business ,law.invention - Published
- 2012
- Full Text
- View/download PDF
8. [How to preserve female fertility before cancer treatments?].
- Author
-
Grynberg M, Poulain M, Le Parco S, Sebag-Peyrelevade S, Frydman N, and Benachi A
- Subjects
- Female, Humans, Fertility Preservation methods, Neoplasms therapy
- Abstract
Over the past decades, major advances in diagnosis and treatment have markedly improved the rates of cure for many young adults and children cancers. As a result, the field of fertility preservation (FP) has developed to overcome the adverse effects of cancer treatments on gonadal function. The strategy of FP will depend on patient's age, the puberty status, and the time frame before the initiation of gonadotoxic treatments. Embryo or oocyte cryopreservation after controlled ovarian hyperstimulation is currently the most established technique of FP, but ovarian tissue freezing may also be offered despite it is still considered experimental. More recently, in vitro maturation (IVM) of oocyte has been proposed in the strategy of FP since it does not require ovarian stimulation and can be performed at any time of the menstrual cycle. Therefore, IVM represents an attractive approach for urgent FP or/and in patients suffering from estrogen-sensitive cancers. In addition, GnRH agonists administration during chemotherapy has also been considered as a technique of FP, with controversial results.
- Published
- 2013
9. Ovarian tissue and follicle transplantation as an option for fertility preservation.
- Author
-
Grynberg M, Poulain M, Sebag-Peyrelevade S, le Parco S, Fanchin R, and Frydman N
- Subjects
- Female, Humans, Neoplasms therapy, Transplantation, Autologous trends, Cryopreservation trends, Infertility, Female prevention & control, Infertility, Female surgery, Ovarian Follicle transplantation, Ovary transplantation
- Abstract
Objective: To review and summarize data from the scientific literature on ovarian tissue and follicle transplantation as an option for fertility preservation., Design: Review of pertinent literature., Setting: University hospital., Patient(s): Women having undergone ovarian tissue transplantation., Intervention(s): None., Main Outcome Measure(s): Review of the literature., Result(s): Over the last decade, the field of ovarian transplantation and cryopreservation has significantly progressed, becoming applicable in humans. Indeed, fresh and frozen cortical ovarian tissue transplantations have been successfully reported worldwide, resulting in around 28 healthy babies. Although ovarian-tissue harvesting seems to be safe, the risk of reimplantation of cancer from ovarian cortical transplants cannot be estimated at this time. As a consequence, auto-transplantation of ovarian tissue in women having suffered from systemic hematological malignancies is not recommended. In these situations, reimplantation of isolated ovarian follicles might represent an interesting option in the future., Conclusion(s): Although the clinical experience is limited, the robust results obtained open new perspectives for the management of premature ovarian failure resulting or not from gonadotoxic treatments., (Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.